Thrombocytopenia: the good, the bad and the ugly

被引:8
作者
Ashworth, Iona [1 ,2 ]
Thielemans, Lieze [3 ]
Chevassut, Timothy [1 ,2 ]
机构
[1] Univ Hosp Sussex NHS Fdn Trust, Haematol, Brighton, E Sussex, England
[2] Brighton & Sussex Med Sch, Brighton, E Sussex, England
[3] Univ Hosp Sussex NHS Fdn Trust, Brighton, E Sussex, England
关键词
thrombocytopenia; thrombosis; bleeding; platelets; haematology; HEPARIN-INDUCED THROMBOCYTOPENIA; MANAGEMENT; GUIDELINES; DIAGNOSIS;
D O I
10.7861/clinmed.2022-0146
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
New thrombocytopenia may be associated with a variety of conditions and diagnosis can be challenging. Presentation can vary from life-threatening bleeding or thrombosis to an incidental finding in an asymptomatic patient. New thrombocytopenia requires urgent investigation. Investigations are mainly guided by findings from the clinical history, physical examination, full blood count and blood film analysis. Aside from the actively bleeding patient, rare but life-threatening causes of thrombocytopenia must be identified early as they require urgent treatment. These include thrombotic thrombocytopenic purpura, disseminated intravascular coagulation, suspicion of new acute promyelocytic leukaemia, and vaccine-induced prothrombotic immune thrombocytopenia. Here, we discuss how to approach a patient with new thrombocytopenia, along with key differentials not to be missed.
引用
收藏
页码:214 / 217
页数:4
相关论文
共 17 条
[1]   Guidelines for the use of platelet transfusions [J].
Estcourt, Lise J. ;
Birchall, Janet ;
Allard, Shubha ;
Bassey, Stephen J. ;
Hersey, Peter ;
Kerr, Jonathan Paul ;
Mumford, Andrew D. ;
Stanworth, Simon J. ;
Tinegate, Hazel .
BRITISH JOURNAL OF HAEMATOLOGY, 2017, 176 (03) :365-394
[2]   Haemolytic uraemic syndrome [J].
Fakhouri, Fadi ;
Zuber, Julien ;
Fremeaux-Bacchi, Veronique ;
Loirat, Chantal .
LANCET, 2017, 390 (10095) :681-696
[3]   How I treat thrombocytopenia in pregnancy [J].
Gernsheimer, Terry ;
James, Andra H. ;
Stasi, Roberto .
BLOOD, 2013, 121 (01) :38-47
[4]   The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study [J].
Girolami, B ;
Prandoni, P ;
Stefani, PM ;
Tanduo, C ;
Sabbion, P ;
Eichler, P ;
Ramon, R ;
Baggio, G ;
Fabris, F ;
Girolami, A .
BLOOD, 2003, 101 (08) :2955-2959
[5]   Vaccine-induced immune thrombotic thrombocytopenia [J].
Klok, Frederikus A. ;
Pai, Menaka ;
Huisman, Menno, V ;
Makris, Michael .
LANCET HAEMATOLOGY, 2022, 9 (01) :E73-E80
[6]  
Levi M, 2009, BRIT J HAEMATOL, V145, P24, DOI [10.1111/j.1365-2141.2009.07600.x, 10.1111/j.1365-2141.2008.07445.x]
[7]   Risk for heparin-induced thrombocytopenia. with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis [J].
Martel, N ;
Lee, J ;
Wells, PS .
BLOOD, 2005, 106 (08) :2710-2715
[8]   Outcomes in patients with atypical hemolytic uremic syndrome treated with eculizumab in a long-term observational study [J].
Menne, Jan ;
Delmas, Yahsou ;
Fakhouri, Fadi ;
Licht, Christoph ;
Lommele, Asa ;
Minetti, Enrico E. ;
Provot, Francois ;
Rondeau, Eric ;
Sheerin, Neil S. ;
Wang, Jimmy ;
Weekers, Laurent E. ;
Greenbaum, Larry A. .
BMC NEPHROLOGY, 2019, 20 (1)
[9]   Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis [J].
Pavord, Sue ;
Scully, Marie ;
Hunt, Beverley J. ;
Lester, William ;
Bagot, Catherine ;
Craven, Brian ;
Rampotas, Alex ;
Ambler, Gareth ;
Makris, Mike .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (18) :1680-1689
[10]   International consensus report on the investigation and management of primary immune thrombocytopenia [J].
Provan, Drew ;
Stasi, Roberto ;
Newland, Adrian C. ;
Blanchette, Victor S. ;
Bolton-Maggs, Paula ;
Bussel, James B. ;
Chong, Beng H. ;
Cines, Douglas B. ;
Gernsheimer, Terry B. ;
Godeau, Bertrand ;
Grainger, John ;
Greer, Ian ;
Hunt, Beverley J. ;
Imbach, Paul A. ;
Lyons, Gordon ;
McMillan, Robert ;
Rodeghiero, Francesco ;
Sanz, Miguel A. ;
Tarantino, Michael ;
Watson, Shirley ;
Young, Joan ;
Kuter, David J. .
BLOOD, 2010, 115 (02) :168-186